Toronto, ON, Canada--Therapeutic laser company Theralase Technologies (TSX-V: TLT) launched its new head office and multidisciplinary therapeutic laser center in the heart of the Beach District of Toronto, ON, Canada. The new laser center will provide local patients with a proven, highly effective, non-invasive light treatment to address painful and inflamed medical conditions, without the need for surgery or pharmaceutical drugs and their associated side effects.
"The Centre will be a multidisciplinary pain and rehabilitation treatment centre focused on delivering Theralase therapeutic laser therapy (http://www.laserfocusworld.com/articles/print/volume-45/issue-7/features/photonics-applied-photonics-in-medicine-low-level-light-therapy-itrsquos-all-about-wavelength-and-power.html) treatments through mainstream medical practitioners, such as: medical doctors, chiropractors, physical therapists, naturopathic doctors, doctors of podiatry and registered massage therapists," said Dr. Rhonda Mostyn, clinic director of Theralase Therapeutic Laser Centre. "Our initial focus will be primarily chronic and acute pain caused by neural muscular skeletal conditions, sports injuries, motor vehicle accidents or trauma, but as the centre grows, we may branch out into other disciplines such as wound healing and addiction."
"With regards to our growing number of customers, the new training facility will provide state of the art conferencing technology and training sessions on our cutting-edge technology, laser therapy certification courses and the latest treatment protocol optimization support," said Roger Dumoulin White, president and CEO of Theralase Technologies.
"The new corporate head office, in addition to housing executive management, finance, sales and marketing functions will also support an ISO-13485 certified, Health Canada, FDA and CE approved facility to manufacture the Theralase line of therapeutic lasers, as well as aftermarket sales and service support for all of Theralase's healthcare customers. Thousands of satisfied healthcare practitioners and patients throughout North America attest to the safety and effectiveness of Theralase's laser technology. We expect the laser centre to be very successful in the near term adding a significant revenue stream to the Company."
The corporate head office and therapeutic laser centre will now be located at 1945 Queen Street East, Toronto, ON, Canada, M4L 1H7; phone: 416-699-LASE (5273), toll-free: 1-866-843-LASE (5273), fax: 416-699-5250, and will be open from 7 am to 7 pm 7 days a week to fully service our local patients and our international sales team.
Founded in 1995, Theralase designs, develops, manufactures, and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications to treat pain, inflammation, and for tissue regeneration of neuromusculoskeletal conditions and wound healing. Theralase is currently developing proprietary photodynamic compounds (PDCs) that are able to target and destroy cancers, bacteria, and viruses when light-activated by Theralase’s proprietary and patented laser technology.
SOURCE: Theralase; http://www.theralase.com/press/b8219820dc241f46ab8bd865d106a980.pdf
